Cargando…
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
BACKGROUND: Patients with stage II to III breast cancer have a high recurrence rate. The early detection of recurrent breast cancer remains a major unmet need. Circulating tumor DNA (ctDNA) has been proven to be a marker of disease progression in metastatic breast cancer. We aimed to evaluate the pr...
Autores principales: | Lin, Po-Han, Wang, Ming-Yang, Lo, Chiao, Tsai, Li-Wei, Yen, Tzu-Chun, Huang, Thomas Yoyan, Huang, Wei-Chih, Yang, Karen, Chen, Chih-Kai, Fan, Sheng-Chih, Kuo, Sung-Hsin, Huang, Chiun-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632818/ https://www.ncbi.nlm.nih.gov/pubmed/34868925 http://dx.doi.org/10.3389/fonc.2021.736769 |
Ejemplares similares
-
Using next‐generation sequencing to redefine BRCAness in triple‐negative breast cancer
por: Lin, Po‐Han, et al.
Publicado: (2020) -
Is Immediate Lymphatic Reconstruction on Breast Cancer Patients Oncologically Safe? A Preliminary Study
por: Lin, Ying-Sheng, et al.
Publicado: (2023) -
Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer
por: Chen, Yen-Cheng, et al.
Publicado: (2021) -
Biocompatibility and Biological Performance Evaluation of Additive-Manufactured Bioabsorbable Iron-Based Porous Suture Anchor in a Rabbit Model
por: Tai, Chien-Cheng, et al.
Publicado: (2021) -
Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value
por: Tseng, Chia-Cheng, et al.
Publicado: (2013)